{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["DUSP1", "HXL131", "L-phenylalanine dipeptide", "TNFSF9", "cell growth and metastasis", "prostate cancer", "proteomics"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36142828", "DateCompleted": {"Year": "2022", "Month": "09", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "18"}], "Language": ["eng"], "ELocationID": ["10916", "10.3390/ijms231810916"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "18", "PubDate": {"Year": "2022", "Month": "Sep", "Day": "18"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9.", "Abstract": {"AbstractText": ["Prostate cancer (PCa) is a common malignant cancer of the urinary system. Drug therapy, chemotherapy, and radical prostatectomy are the primary treatment methods, but drug resistance and postoperative recurrence often occur. Therefore, seeking novel anti-tumor compounds with high efficiency and low toxicity from natural products can produce a new tumor treatment method. Matijin-Su [<i>N</i>-(<i>N</i>-benzoyl-L-phenylalanyl)-<i>O</i>-acetyl-L-phenylalanol, MTS] is a phenylalanine dipeptide monomer compound that is isolated from the Chinese ethnic medicine Matijin (<i>Dichondra repens</i> Forst.). Its derivatives exhibit various pharmacological activities, especially anti-tumor. Among them, the novel MTS derivative HXL131 has a significant inhibitory effect against prostate tumor growth and metastasis. This study is designed to investigate the effects of HXL131 on the growth and metastasis of human PCa cell lines PC3 and its molecular mechanism through in vitro experiments combined with proteomics, molecular docking, and gene silencing. The in vitro results showed that HXL131 concentration dependently inhibited PC3 cell proliferation, induced apoptosis, arrested cell cycle at the G2/M phase, and inhibited cell migration capacity. A proteomic analysis and a Western blot showed that HXL131 up-regulated the expression of proliferation, apoptosis, cell cycle, and migration-related proteins CYR61, TIMP1, SOD2, IL6, SERPINE2, DUSP1, TNFSF9, OSMR, TNFRSF10D, and TNFRSF12A. Molecular docking, a cellular thermal shift assay (CETSA), and gene silencing showed that HXL131 had a strong binding affinity with DUSP1 and TNFSF9, which are important target genes for inhibiting the growth and metastasis of PC3 cells. This study demonstrates that HXL131 exhibited excellent anti-prostate cancer activity and inhibited the growth and metastasis of prostate cancer cells by regulating the expression of DUSP1 and TNFSF9."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550025, China."}], "LastName": "Li", "ForeName": "Lanlan", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}], "LastName": "Yang", "ForeName": "Mingfei", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Yu", "ForeName": "Jia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Cheng", "ForeName": "Sha", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}], "LastName": "Ahmad", "ForeName": "Mashaal", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550025, China."}], "LastName": "Wu", "ForeName": "Caihong", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}], "LastName": "Wan", "ForeName": "Xinwei", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Xu", "ForeName": "Bixue", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}, {"Identifier": ["0000-0001-6839-1659"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Luo", "ForeName": "Heng", "Initials": "H"}], "GrantList": [{"GrantID": "No. QKHZC [2022]194", "Agency": "The Science and Technology Planning Project of Guizhou Province", "Country": ""}, {"GrantID": "No. QKHJC-ZK [2022]ZD031", "Agency": "The main projects of the Natural Science Foundation of Guizhou province", "Country": ""}, {"GrantID": "QKHPTRC-GCC[2022]034-1", "Agency": "Guizhou province \"Hundred\" level innovative talent training project", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "4-1BB Ligand"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Dipeptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}, {"RegistryNumber": "0", "NameOfSubstance": "Serpin E2"}, {"RegistryNumber": "0", "NameOfSubstance": "TNFSF9 protein, human"}, {"RegistryNumber": "47E5O17Y3R", "NameOfSubstance": "Phenylalanine"}, {"RegistryNumber": "EC 3.1.3.48", "NameOfSubstance": "DUSP1 protein, human"}, {"RegistryNumber": "EC 3.1.3.48", "NameOfSubstance": "Dual Specificity Phosphatase 1"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "4-1BB Ligand"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Movement"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Dipeptides"}, {"QualifierName": ["genetics"], "DescriptorName": "Dual Specificity Phosphatase 1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Interleukin-6"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Phenylalanine"}, {"QualifierName": ["metabolism"], "DescriptorName": "Prostatic Neoplasms"}, {"QualifierName": [], "DescriptorName": "Proteomics"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Serpin E2"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Liao J., Song Q., Li J., Du K., Chen Y., Zou C., Mo Z. Carcinogenic effect of adenylosuccinate lyase (ADSL) in prostate cancer development and progression through the cell cycle pathway. Cancer Cell Int. 2021;21:467. doi: 10.1186/s12935-021-02174-6.", "ArticleIdList": ["10.1186/s12935-021-02174-6", "PMC8419980", "34488772"]}, {"Citation": "Zhu Z., Luo L., Xiang Q., Wang J., Liu Y., Deng Y., Zhao Z. MiRNA-671-5p Promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis. Cell Death Dis. 2020;11:949. doi: 10.1038/s41419-020-03138-w.", "ArticleIdList": ["10.1038/s41419-020-03138-w", "PMC7642259", "33144585"]}, {"Citation": "Raspantini G.L., Luiz M.T., Abriata J.P., de Oliveira Eloy J., Vaidergorn M.M., da Silva Emery F., Marchetti J.M. PCL-TPGS polymeric nanoparticles for docetaxel delivery to prostate cancer: Development, physicochemical and biological characterization. Colloids Surfaces A Physicochem. Eng. Asp. 2021;627:127144. doi: 10.1016/j.colsurfa.2021.127144.", "ArticleIdList": ["10.1016/j.colsurfa.2021.127144"]}, {"Citation": "Yap T.A., Smith A.D., Ferraldeschi R., Al-Lazikani B., Workman P., de Bono J.S. Drug discovery in advanced prostate cancer: Translating biology into therapy. Nat. Rev. Drug Discov. 2016;15:699\u2013718. doi: 10.1038/nrd.2016.120.", "ArticleIdList": ["10.1038/nrd.2016.120", "27444228"]}, {"Citation": "Barlow S.K., Oyekunle T., Janes J.L., De Hoedt A.M., Aronson W.J., Kane C.J., Amling C.L., Cooperberg M.R., Klaassen Z.W., Terris M.K., et al. Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort study. Prostate. 2022;82:366\u2013372. doi: 10.1002/pros.24283.", "ArticleIdList": ["10.1002/pros.24283", "34905632"]}, {"Citation": "Cellini F., Tagliaferri L., Frascino V., Alitto A.R., Fionda B., Boldrini L., Romano A., Cas\u00e0 C., Catucci F., Mattiucci G.C., et al. Radiation therapy for prostate cancer: What\u2019s the best in 2021. Urologia. 2022;89:5\u201315. doi: 10.1177/03915603211042335.", "ArticleIdList": ["10.1177/03915603211042335", "34496707"]}, {"Citation": "Kamran S.C., D\u2019Amico A.V. Radiation Therapy for Prostate Cancer. Hematol. Oncol. Clin. N. Am. 2020;34:45\u201369. doi: 10.1016/j.hoc.2019.08.017.", "ArticleIdList": ["10.1016/j.hoc.2019.08.017", "31739952"]}, {"Citation": "Lopez W., Nguyen N., Cao J., Eddow C., Shung K.K., Lee N.S., Chow M. Ultrasound Therapy, Chemotherapy and Their Combination for Prostate Cancer. Technol. Cancer Res. Treat. 2021;20:15330338211011965. doi: 10.1177/15330338211011965.", "ArticleIdList": ["10.1177/15330338211011965", "PMC8141993", "34013821"]}, {"Citation": "Schr\u00f6der F.H. Early versus delayed endocrine therapy for prostate cancer. Endocr. Relat. Cancer. 2007;14:1\u201311. doi: 10.1677/ERC-06-0022.", "ArticleIdList": ["10.1677/ERC-06-0022", "17395971"]}, {"Citation": "Yao Q., Wang Y., Dong Z., Lai C., Chang B., Gong Q., Ren S., Sun D., Lu J., Gao Y. Dichondra repens J.R.Forst. and G.Forst.: A Review of Its Traditional Uses, Chemistry, Pharmacology, Toxicology and Applications. Front. Pharmacol. 2020;11:608199. doi: 10.3389/fphar.2020.608199.", "ArticleIdList": ["10.3389/fphar.2020.608199", "PMC7908059", "33643039"]}, {"Citation": "Liu X., Xue L., Zhang H., Xu Q., Zhang S., Ma S., Ding X., Liu L., Dong J., Qian L., et al. Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects. Clin. Drug Investig. 2020;40:555\u2013566. doi: 10.1007/s40261-020-00909-3.", "ArticleIdList": ["10.1007/s40261-020-00909-3", "32277364"]}, {"Citation": "Liu X., Ma C., Liu Z., Kang W. Natural Products: Review for Their Effects of Anti-HBV. BioMed Res. Int. 2020;2020:3972390. doi: 10.1155/2020/3972390.", "ArticleIdList": ["10.1155/2020/3972390", "PMC7746453", "33376721"]}, {"Citation": "Xu B., Huang Z., Liu C., Cai Z., Pan W., Cao P., Hao X., Liang G. Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives. Bioorganic Med. Chem. 2009;17:3118\u20133125. doi: 10.1016/j.bmc.2009.03.003.", "ArticleIdList": ["10.1016/j.bmc.2009.03.003", "19307124"]}, {"Citation": "Cui J. Synthesis and anti-HBV activity evaluation of Matijin-Su derivatives containing trifluoromethyl. Chin. Pharmacol. J. 2019;24:1045\u20131053."}, {"Citation": "Guo D., Zhang Y., Zhao J., He H., Hou T. Selenium-biofortified corn peptides: Attenuating concanavalin A-Induced liver injury and structure characterization. J. Trace Elem. Med. Biol. 2019;51:57\u201364. doi: 10.1016/j.jtemb.2018.09.010.", "ArticleIdList": ["10.1016/j.jtemb.2018.09.010", "30466939"]}, {"Citation": "Xu B., Wang N., Pan W., Qiu J., Cao P., Zhu M., Feng Y., Liang G. Synthesis and anti-tumor activity evaluation of Matijin-Su derivatives. Bioorganic Chem. 2014;56:34\u201340. doi: 10.1016/j.bioorg.2014.05.009.", "ArticleIdList": ["10.1016/j.bioorg.2014.05.009", "24930072"]}, {"Citation": "Qiu J., Xu B., Gong Q., Pan W., Liu C., Huang Z., Gu X., Liang G. Synthesis and Biological Evaluation of Matijin-Su Derivatives as Potential Antihepatitis B Virus and Anticancer Agents. Chem. Biodivers. 2016;13:1584\u20131592. doi: 10.1002/cbdv.201600113.", "ArticleIdList": ["10.1002/cbdv.201600113", "27451105"]}, {"Citation": "Qiu J., Xu B., Huang Z., Pan W., Cao P., Liu C., Hao X., Song B., Liang G. Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents. Bioorganic Med. Chem. 2011;19:5352\u20135360. doi: 10.1016/j.bmc.2011.08.001.", "ArticleIdList": ["10.1016/j.bmc.2011.08.001", "21872478"]}, {"Citation": "Kuang A., Lu W., Zeng X., Liang G., Xu B. Synthesis and anti-HBV activity evaluation of Matijin-Su derivatives containing veratric acid. Chin. J. New Drug. 2019;28:1523\u20131530."}, {"Citation": "Li W., Xu F., Shuai W., Sun H., Yao H., Ma C., Xu S., Yao H., Zhu Z., Yang D.H., et al. Discovery of Novel Quinoline-Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity. J. Med. Chem. 2019;62:993\u20131013. doi: 10.1021/acs.jmedchem.8b01755.", "ArticleIdList": ["10.1021/acs.jmedchem.8b01755", "30525584"]}, {"Citation": "Li H., Hung A., Yang A. Herb-target virtual screening and network pharmacology for prediction of molecular mechanism of Danggui Beimu Kushen Wan for prostate cancer. Sci. Rep. 2021;11:6656. doi: 10.1038/s41598-021-86141-1.", "ArticleIdList": ["10.1038/s41598-021-86141-1", "PMC7988104", "33758314"]}, {"Citation": "Shen J., Zhang Y., Yu H., Shen B., Liang Y., Jin R., Liu X., Shi L., Cai X. Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy. Cancer Med. 2016;5:2061\u20132068. doi: 10.1002/cam4.772.", "ArticleIdList": ["10.1002/cam4.772", "PMC4884638", "27227569"]}, {"Citation": "Mart\u00ednez-Mart\u00ednez D., Soto A., Gil-Araujo B., Gallego B., Chiloeches A., Lasa M. Resveratrol promotes apoptosis through the induction of dual specificity phosphatase 1 and sensitizes prostate cancer cells to cisplatin. Food Chem. Toxicol. 2019;124:273\u2013279. doi: 10.1016/j.fct.2018.12.014.", "ArticleIdList": ["10.1016/j.fct.2018.12.014", "30552915"]}, {"Citation": "Shen J., Zhou S., Shi L., Liu X., Lin H., Yu H., Xiaoliang, Tang J., Yu T., Cai X. DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer. Oncotarget. 2017;8:12133\u201312144. doi: 10.18632/oncotarget.14815.", "ArticleIdList": ["10.18632/oncotarget.14815", "PMC5355331", "28129656"]}, {"Citation": "Zhang X., Hyer J.M., Yu H., D\u2019Silva N.J., Kirkwood K.L. DUSP1 phosphatase regulates the proinflammatory milieu in head and neck squamous cell carcinoma. Cancer Res. 2014;74:7191\u20137197. doi: 10.1158/0008-5472.CAN-14-1379.", "ArticleIdList": ["10.1158/0008-5472.CAN-14-1379", "PMC4268021", "25312268"]}, {"Citation": "Pan S., Shen M., Zhou M., Shi X., He R., Yin T., Wang M., Guo X., Qin R. Long noncoding RNA LINC01111 suppresses pancreatic cancer aggressiveness by regulating DUSP1 expression via microRNA-3924. Cell Death Dis. 2019;10:883. doi: 10.1038/s41419-019-2123-y.", "ArticleIdList": ["10.1038/s41419-019-2123-y", "PMC6877515", "31767833"]}, {"Citation": "Kho D.H., Uddin M.H., Chatterjee M., Vogt A., Raz A., Wu G.S. GP78 Cooperates with Dual-Specificity Phosphatase 1 to Stimulate Epidermal Growth Factor Receptor-Mediated Extracellular Signal-Regulated Kinase Signaling. Mol. Cell. Biol. 2019;39:e00485-18. doi: 10.1128/MCB.00485-18.", "ArticleIdList": ["10.1128/MCB.00485-18", "PMC6517599", "31061093"]}, {"Citation": "Gil-Araujo B., Toledo Lobo M.V., Guti\u00e9rrez-Salmer\u00f3n M., Guti\u00e9rrez-Pital\u00faa J., Ropero S., Angulo J.C., Chiloeches A., Lasa M. Dual specificity phosphatase 1 expression inversely correlates with NF-\u03baB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism. Mol. Oncol. 2014;8:27\u201338. doi: 10.1016/j.molonc.2013.08.012.", "ArticleIdList": ["10.1016/j.molonc.2013.08.012", "PMC5528511", "24080497"]}, {"Citation": "Mart\u00ednez-Mart\u00ednez D., Toledo Lobo M.V., Baquero P., Ropero S., Angulo J.C., Chiloeches A., Lasa M. Downregulation of Snail by DUSP1 Impairs Cell Migration and Invasion through the Inactivation of JNK and ERK and Is Useful as a Predictive Factor in the Prognosis of Prostate Cancer. Cancers. 2021;13:1158. doi: 10.3390/cancers13051158.", "ArticleIdList": ["10.3390/cancers13051158", "PMC7962644", "33800291"]}, {"Citation": "Shen Y.L., Gan Y., Gao H.F., Fan Y.C., Wang Q., Yuan H., Song Y.F., Wang J.D., Tu H. TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma. J. Dig. Dis. 2017;18:395\u2013403. doi: 10.1111/1751-2980.12489.", "ArticleIdList": ["10.1111/1751-2980.12489", "28547807"]}, {"Citation": "Wu J., Wang Y., Jiang Z. TNFSF9 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer. J. Gastrointest. Cancer. 2021;52:150\u2013159. doi: 10.1007/s12029-020-00371-6.", "ArticleIdList": ["10.1007/s12029-020-00371-6", "32077004"]}, {"Citation": "Gong G., Shen Y.L., Lan H.Y., Jin J.M., An P., Zhang L.J., Chen L.L., Peng W., Luan X., Zhang H. The Cyr61 Is a Potential Target for Rotundifuran, a Natural Labdane-Type Diterpene from Vitex trifolia L., to Trigger Apoptosis of Cervical Cancer Cells. Oxidative Med. Cell. Longev. 2021;2021:6677687. doi: 10.1155/2021/6677687.", "ArticleIdList": ["10.1155/2021/6677687", "PMC8218918", "34234887"]}, {"Citation": "Chien W., Kumagai T., Miller C.W., Desmond J.C., Frank J.M., Said J.W., Koeffler H.P. Cyr61 suppresses growth of human endometrial cancer cells. J. Biol. Chem. 2004;279:53087\u201353096. doi: 10.1074/jbc.M410254200.", "ArticleIdList": ["10.1074/jbc.M410254200", "15471875"]}, {"Citation": "Tanaka F., Rizqiawan A., Higashikawa K., Tobiume K., Okui G., Shigeishi H., Ono S., Shimasue H., Kamata N. Snail promotes Cyr61 secretion to prime collective cell migration and form invasive tumor nests in squamous cell carcinoma. Cancer Lett. 2013;329:243\u2013252. doi: 10.1016/j.canlet.2012.11.023.", "ArticleIdList": ["10.1016/j.canlet.2012.11.023", "23196056"]}, {"Citation": "Tong X., O\u2019Kelly J., Xie D., Mori A., Lemp N., McKenna R., Miller C.W., Koeffler H.P. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway. Oncogene. 2004;23:4847\u20134855. doi: 10.1038/sj.onc.1207628.", "ArticleIdList": ["10.1038/sj.onc.1207628", "15077166"]}, {"Citation": "Kim H., Son S., Ko Y., Lee J.E., Kim S., Shin I. YAP, CTGF and Cyr61 are overexpressed in tamoxifen-resistant breast cancer and induce transcriptional repression of ER\u03b1. J. Cell Sci. 2021;134:jcs256503. doi: 10.1242/jcs.256503.", "ArticleIdList": ["10.1242/jcs.256503", "34096606"]}, {"Citation": "Da Silva-\u00c1lvarez S., Collado M. The Jekyll and Hyde of Senescence in Cancer: TIMP1 Controls the Switch from Tumor-Controlling to Tumor-Promoting Senescence. Cancer Cell. 2021;39:13\u201315. doi: 10.1016/j.ccell.2020.12.013.", "ArticleIdList": ["10.1016/j.ccell.2020.12.013", "33357453"]}, {"Citation": "Rabelo-Santos S.H., Termini L., Boccardo E., Derchain S., Longatto-Filho A., Andreoli M.A., Costa M.C., Lima Nunes R.A., Lucci \u00c2ngelo-Andrade L.A., Villa L.L., et al. Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer. Oncotarget. 2018;9:21630\u201321640. doi: 10.18632/oncotarget.24850.", "ArticleIdList": ["10.18632/oncotarget.24850", "PMC5955150", "29774090"]}, {"Citation": "Mumyatova V.A., Balakina A.A., Lapshina M.A., Sen\u2019 V.D., Kornev A.B., Terent\u2019ev A.A. Influence of Tumor Suppressor p53 Functioning on the Expression of Antioxidant System Genes under the Action of Cytotoxic Compounds. Bull. Exp. Biol. Med. 2020;169:169\u2013175. doi: 10.1007/s10517-020-04844-3.", "ArticleIdList": ["10.1007/s10517-020-04844-3", "32504383"]}, {"Citation": "Kim J.W., Gautam J., Kim J.E., Kim J.A., Kang K.W. Inhibition of tumor growth and angiogenesis of tamoxifen-resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor. Oncol. Lett. 2019;17:3981\u20133989. doi: 10.3892/ol.2019.10059.", "ArticleIdList": ["10.3892/ol.2019.10059", "PMC6425385", "30930994"]}, {"Citation": "Fakhri S., Moradi S.Z., Ash-Rafzadeh A., Bishayee A. Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review. Pharmacol. Res. 2022;177:105961. doi: 10.1016/j.phrs.2021.105961.", "ArticleIdList": ["10.1016/j.phrs.2021.105961", "34718135"]}, {"Citation": "Ibrahim M.L., Lu C., Klement J.D., Redd P.S., Yang D., Smith A.D., Liu K. Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells. Cancer Immunol. Immunother. 2020;69:2233\u20132245. doi: 10.1007/s00262-020-02620-w.", "ArticleIdList": ["10.1007/s00262-020-02620-w", "32488308"]}, {"Citation": "Tanaka T., Narazaki M., Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb. Perspect. Biol. 2014;6:a016295. doi: 10.1101/cshperspect.a016295.", "ArticleIdList": ["10.1101/cshperspect.a016295", "PMC4176007", "25190079"]}, {"Citation": "Johnson D.E., O\u2019Keefe R.A., Grandis J.R. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat. Rev. Clin. Oncol. 2018;15:234\u2013248. doi: 10.1038/nrclinonc.2018.8.", "ArticleIdList": ["10.1038/nrclinonc.2018.8", "PMC5858971", "29405201"]}, {"Citation": "Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int. Immunol. 2021;33:127\u2013148. doi: 10.1093/intimm/dxaa078.", "ArticleIdList": ["10.1093/intimm/dxaa078", "PMC7799025", "33337480"]}, {"Citation": "Li L., Yu J., Cheng S., Peng Z., Luo H. Transcription factor Fli-1 as a new target for antitumor drug development. Int. J. Biol. Macromol. 2022;209:1155\u20131168. doi: 10.1016/j.ijbiomac.2022.04.076.", "ArticleIdList": ["10.1016/j.ijbiomac.2022.04.076", "35447268"]}, {"Citation": "Xia T., Li J., Ren X., Liu C., Sun C. Research progress of phenolic compounds regulating IL-6 to exert antitumor effects. Phytother. Res. 2021;35:6720\u20136734. doi: 10.1002/ptr.7258.", "ArticleIdList": ["10.1002/ptr.7258", "34427003"]}, {"Citation": "Fisher D.T., Appenheimer M.M., Evans S.S. The two faces of IL-6 in the tumor microenvironment. Semin. Immunol. 2014;26:38\u201347. doi: 10.1016/j.smim.2014.01.008.", "ArticleIdList": ["10.1016/j.smim.2014.01.008", "PMC3970580", "24602448"]}, {"Citation": "Pagliara V., Adornetto A., Mamm\u00ec M., Masullo M., Sarnataro D., Pietropaolo C., Arcone R. Protease Nexin-1 affects the migration and invasion of C6 glioma cells through the regulation of urokinase Plasminogen Activator and Matrix Metalloproteinase-9/2. Biochim. Biophys. Acta. 2014;1843:2631\u20132644. doi: 10.1016/j.bbamcr.2014.07.008.", "ArticleIdList": ["10.1016/j.bbamcr.2014.07.008", "25072751"]}, {"Citation": "Xu D., McKee C.M., Cao Y., Ding Y., Kessler B.M., Muschel R.J. Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1. Cancer Res. 2010;70:6988\u20136998. doi: 10.1158/0008-5472.CAN-10-0242.", "ArticleIdList": ["10.1158/0008-5472.CAN-10-0242", "PMC3272441", "20736374"]}, {"Citation": "Hibi K., Goto T., Sakuraba K., Shirahata A., Saito M., Ishibashi K., Kigawa G., Nemoto H., Sanada Y. Methylation of OSMR gene is frequently observed in non-invasive colorectal cancer. Anticancer Res. 2011;31:1293\u20131295.", "ArticleIdList": ["21508378"]}, {"Citation": "Jahani-Asl A., Yin H., Soleimani V.D., Haque T., Luchman H.A., Chang N.C., Sincennes M.C., Puram S.V., Scott A.M., Lorimer I.A., et al. Control of glioblastoma tumorigenesis by feed-forward cytokine signaling. Nat. Neurosci. 2016;19:798\u2013806. doi: 10.1038/nn.4295.", "ArticleIdList": ["10.1038/nn.4295", "PMC4984527", "27110918"]}, {"Citation": "Liu Z., Zhong J., Cai C., Lu J., Wu W., Zeng G. Immune-related biomarker risk score predicts prognosis in prostate cancer. Aging. 2020;12:22776\u201322793. doi: 10.18632/aging.103921.", "ArticleIdList": ["10.18632/aging.103921", "PMC7746334", "33197890"]}, {"Citation": "Wu Z.H., Niu X., Wu G.H., Cheng Q. Decreased expression of TNFRSF12A in thyroid gland cancer predicts poor prognosis: A study based on TCGA data. Medicine. 2020;99:e21882. doi: 10.1097/MD.0000000000021882.", "ArticleIdList": ["10.1097/MD.0000000000021882", "PMC7447363", "32846846"]}, {"Citation": "Naimi A., Movassaghpour A.A., Hagh M.F., Talebi M., Entezari A., Jadidi-Niaragh F., Solali S. TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies. Biomed. Pharmacother. 2018;98:566\u2013576. doi: 10.1016/j.biopha.2017.12.082.", "ArticleIdList": ["10.1016/j.biopha.2017.12.082", "29288972"]}, {"Citation": "Gamie Z., Kapriniotis K., Papanikolaou D., Haagensen E., Da Conceicao Ribeiro R., Dalgarno K., Krippner-Heidenreich A., Gerrand C., Tsiridis E., Rankin K.S. TNF-related apoptosis-inducing ligand (TRAIL) for bone sarcoma treatment: Pre-clinical and clinical data. Cancer Lett. 2017;409:66\u201380. doi: 10.1016/j.canlet.2017.08.036.", "ArticleIdList": ["10.1016/j.canlet.2017.08.036", "28888998"]}, {"Citation": "Zhang Y.Q., Wen Z.H., Wan K., Yuan D., Zeng X., Liang G., Zhu J., Xu B., Luo H. A novel synthesized 3\u2019, 5\u2019-diprenylated chalcone mediates the proliferation of human leukemia cells by regulating apoptosis and autophagy pathways. Biomed. Pharmacother. 2018;106:794\u2013804. doi: 10.1016/j.biopha.2018.06.153.", "ArticleIdList": ["10.1016/j.biopha.2018.06.153", "29990873"]}, {"Citation": "Karim S., Burzangi A.S., Ahmad A., Siddiqui N.A., Ibrahim I.M., Sharma P., Abualsunun W.A., Gabr G.A. PI3K-AKT Pathway Modulation by Thymoquinone Limits Tumor Growth and Glycolytic Metabolism in Colorectal Cancer. Int. J. Mol. Sci. 2022;23:2305. doi: 10.3390/ijms23042305.", "ArticleIdList": ["10.3390/ijms23042305", "PMC8880628", "35216429"]}, {"Citation": "Fu J., Qin L., He T., Qin J., Hong J., Wong J., Liao L., Xu J. The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res. 2011;21:275\u2013289. doi: 10.1038/cr.2010.118.", "ArticleIdList": ["10.1038/cr.2010.118", "PMC3193433", "20714342"]}, {"Citation": "DU X., Xiao J., Fu X., Xu B., Han H., Wang Y., Pei X. A proteomic analysis of Bcl-2 regulation of cell cycle arrest: Insight into the mechanisms. J. Zhejiang Univ. Sci. B. 2021;22:839\u2013855. doi: 10.1631/jzus.B2000802.", "ArticleIdList": ["10.1631/jzus.B2000802", "PMC8505462", "34636187"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "24"}, {"Year": "2022", "Month": "9", "Day": "12"}, {"Year": "2022", "Month": "9", "Day": "14"}, {"Year": "2022", "Month": "9", "Day": "23", "Hour": "1", "Minute": "26"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["36142828", "PMC9504056", "10.3390/ijms231810916", "ijms231810916"]}}], "PubmedBookArticle": []}